Ovarian Cancer

Protocols
5 protocols meet the specified criteria
Disease Site: Ovarian
Protocol No. Title
13631 Molecular Analysis for Therapy Choice (MATCH)
14692 A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors
15092 An Open-Label Study of Rovalpituzumab Tesirine in Subjects with Delta-Like Protein 3-Expressing Advanced Solid Tumors
15873 A Phase 1/2 study exploring the safety, tolerability, and efficacy of INCAGN01876 in combination with immune therapies in subjects with advanced or metastatic malignancies
16016 DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors